. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

BRI-ABeta Fusion Proteins: A Novel Means for Specific High-Level Expression of ABeta Peptides

Reference #:

2001-023

Inventors/Contributors

Todd E. Golde M.D., Eileen M. McGowan Ph.D., Pritam Das Ph.D.

Description

A novel expression system has been developed that selectively expresses ABeta40 or ABeta42 in the secretory pathway. This system enables expression of high levels of specific ABeta peptides. Such a system has been used to develop animal models that critically determine the pathogenicity of individual ABeta peptides. In addition, the system may have general utility as a means of expressing high-level of small peptides in the secretory pathway of many organisms.

Patent Status

Pending

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410